3,100
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Human biomonitoring of low-level benzene exposures

ORCID Icon
Pages 799-810 | Received 05 Sep 2022, Accepted 27 Jan 2023, Published online: 07 Mar 2023

References

  • Aksoy M, Dincol K, Erdem S, Dincol G. 1972. Acute leukemia due to chronic exposure to benzene. Am J Med. 52(2):160–166.
  • Aksoy M, Erdem S, DinCol G. 1974. Leukemia in shoe-workers exposed chronically to benzene. Blood. 44(6):837–841.
  • Aksoy M, Erdem S, Erdogan G, Dincol G. 1974. Acute leukaemia in two generations following chronic exposure to benzene. Hum Hered. 24(1):70–74.
  • Alegretti AP, Thiesen FV, Maciel GP. 2004. Analytical method for evaluation of exposure to benzene, toluene, xylene in blood by gas chromatography preceded by solid phase microextraction. J Chromatogr B Analyt Technol Biomed Life Sci. 809(1):183–187.
  • Amorim LC, Carneiro JP, Cardeal ZL. 2008. An optimized method for determination of benzene in exhaled air by gas chromatography-mass spectrometry using solid phase microextraction as a sampling technique. J Chromatogr B Analyt Technol Biomed Life Sci. 865(1–2):141–146.
  • Angelini S, Kumar R, Bermejo JL, Maffei F, Barbieri A, Graziosi F, Carbone F, Cantelli-Forti G, Violante FS, Hemminki K, et al. 2011. Exposure to low environmental levels of benzene: evaluation of micronucleus frequencies and S-phenylmercapturic acid excretion in relation to polymorphisms in genes encoding metabolic enzymes. Mutat Res. 719(1–2):7–13.
  • Angerer J, Scherer G, Schaller KH, Mueller J. 1991. The determination of benzene in human blood as an indicator of environmental exposure to volatile aromatic compounds. Fresenius J Anal Chem. 339:740–742.
  • Arnold SM, Angerer J, Boogaard PJ, Hughes MF, O'Lone RB, Robison SH, Schnatter AR. 2013. The use of biomonitoring data in exposure and human health risk assessment: benzene case study. Crit Rev Toxicol. 43(2):119–153.
  • Aston JP, Ball RL, Pople JE, Jones K, Cocker J. 2002. Development and validation of a competitive immunoassay for urinary S-phenylmercapturic acid and its application in benzene biological monitoring. Biomarkers. 7(2):103–112.
  • ATSDR. 2007. Toxicological profile for benzene. Atlanta, Georgia, USA: U.S. Department of Health and Human Services.
  • Bader M, Van Weyenbergh T, Verwerft E, Van Pul J, Lang S, Oberlinner C. 2014. Human biomonitoring after chemical incidents and during short-term maintenance work as a tool for exposure analysis and assessment. Toxicol Lett. 231(3):328–336.
  • Bechtold WE, Sun JD, Birnbaum LS, Yin SN, Li GL, Kasicki S, Lucier G, Henderson RF. 1992. S-phenylcysteine formation in hemoglobin as a biological exposure index to benzene. Arch Toxicol. 66(5):303–309.
  • Bechtold WE, Willis JK, Sun JD, Griffith WC, Reddy TV. 1992. Biological markers of exposure to benzene: s-phenylcysteine in albumin. Carcinogenesis. 13(7):1217–1220.
  • Bogen KT, Sheehan PJ. 2014. Dermal versus total uptake of benzene from mineral spirits solvent during parts washing. Risk Anal. 34(7):1336–1358.
  • Bois FY, Jackson ET, Pekari K, Smith MT. 1996. Population toxicokinetics of benzene. Environ Health Perspect. 104(Suppl 6):1405–1411.
  • Boogaard PJ. 2017. The low-dose benzene debate needs a sharp blade. Chem Biol Interact. 278:239–241.
  • Boogaard PJ, Hays SM, Aylward LL. 2011. Human biomonitoring as a pragmatic tool to support health risk management of chemicals–examples under the EU REACH programme. Regul Toxicol Pharmacol. 59(1):125–132.
  • Boogaard PJ, Money CD. 2008. A proposed framework for the interpretation of biomonitoring data. Environ Health. 7(Suppl 1):S12.
  • Boogaard PJ, van Sittert NJ. 1995. Biological monitoring of exposure to benzene: a comparison between S-phenylmercapturic acid, trans,trans-muconic acid, and phenol. Occup Environ Med. 52(9):611–620.
  • Boogaard PJ, van Sittert NJ. 1996. Suitability of S-phenyl mercapturic acid and trans-trans-muconic acid as biomarkers for exposure to low concentrations of benzene. Environ Health Perspect. 104(Suppl 6):1151–1157.
  • Brown EA, Shelley ML, Fisher JW. 1998. A pharmacokinetic study of occupational and environmental benzene exposure with regard to gender. Risk Anal. 18(2):205–213.
  • Brugnone F, Perbellini L, Maranelli G, Romeo L, Guglielmi G, Lombardini F. 1992. Reference values for blood benzene in the occupationally unexposed general population. Int Arch Occup Environ Health. 64(3):179–184.
  • Brugnone F, Perbellini L, Romeo L, Bianchin M, Tonello A, Pianalto G, Zambon D, Zanon G. 1998. Benzene in environmental air and human blood. Int Arch Occup Environ Health. 71(8):554–559.
  • Brugnone F, Perbellini L, Romeo L, Cerpelloni M, Bianchin M, Tonello A. 1999. Benzene in blood as a biomarker of low level occupational exposure. Sci Total Environ. 235(1–3):247–252.
  • Campagna M, Satta G, Campo L, Flore V, Ibba A, Meloni M, Tocco MG, Avataneo G, Flore C, Fustinoni S, et al. 2012. Biological monitoring of low-level exposure to benzene. Med Lav. 103(5):338–346.
  • Carrer P, Maroni M, Alcini D, Cavallo D, Fustinoni S, Lovato L, Visigalli F. 2000. Assessment through environmental and biological measurements of total daily exposure to volatile organic compounds of office workers in Milan, Italy. Indoor Air. 10(4):258–268.
  • Carrieri M, Tranfo G, Pigini D, Paci E, Salamon F, Scapellato ML, Fracasso ME, Manno M, Bartolucci GB. 2010. Correlation between environmental and biological monitoring of exposure to benzene in petrochemical industry operators. Toxicol Lett. 192(1):17–21.
  • Cox LA, Schnatter AR, Boogaard PJ, Banton M, Ketelslegers HB. 2017. Non-parametric estimation of low-concentration benzene metabolism. Chem Biol Interact. 278:242–255.
  • DECOS. 2014. Benzene – health-based recommended occupational exposure limit. Den Haag: D. E. C. o. O. Safety. Health Council of the Netherlands.
  • DFG. 2013. MAK- und BAT-Werte-Liste 2013. Weinheim (Germany): Wiley VCH.
  • DFG. 2017. MAK-und BAT-Werte Liste 2017. Weinheim (Germany): Wiley VCH.
  • DFG. 2018. Addendum zu Benzol. The MAK Collect Occup Health Safe. 3:262–294.
  • Ducos P, Gaudin R, Bel J, Maire C, Francin JM, Robert A, Wild P. 1992. Trans-muconic acid, a reliable biological indicator for the detection of individual benzene exposure down to the ppm level. Int Arch Occup Environ Health. 64(5):309–313.
  • Ducos P, Gaudin R, Robert A, Francin JM, Maire C. 1990. Improvement in HPLC analysis of urinary trans,trans-muconic acid, a promising substitute for phenol in the assessment of benzene exposure. Int Arch Occup Environ Health. 62(7):529–534.
  • EC. 2022. Directive (EU) of the European Parliament and the Council of 9 March 2022 amending Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens and mutagens at work. Official Journal of the European Union L88/1: directive (EU) of the European Parliament and the Council of 9 March 2022 amending Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens and mutagens at work. European Parliament and the European Council of the European Union; Official Journal of the European Union, L158, p. 50.
  • Folin O, Denis W. 1915. A colorimetric method for the determination of phenols (and phenol derivatives) in urine. J Biol Chem. 22(3):305–308.
  • Forsell K, Liljelind I, Ljungkvist G, Nordlinder R, Andersson E, Nilsson R. 2019. Benzene exposure and biomarkers in alveolar air and urine among deck crews on tankers transporting gasoline. Ann Work Expo Health. 63(8):890–897.
  • Fracasso ME, Doria D, Bartolucci GB, Carrieri M, Lovreglio P, Ballini A, Soleo L, Tranfo G, Manno M. 2010. Low air levels of benzene: correlation between biomarkers of exposure and genotoxic effects. Toxicol Lett. 192(1):22–28.
  • Fustinoni S, Consonni D, Campo L, Buratti M, Colombi A, Pesatori AC, Bonzini M, Bertazzi PA, Foa V, Garte S, et al. 2005. Monitoring low benzene exposure: comparative evaluation of urinary biomarkers, influence of cigarette smoking, and genetic polymorphisms. Cancer Epidemiol Biomarkers Prev. 14(9):2237–2244.
  • Ghittori S, Fiorentino ML, Maestri L, Cordioli G, Imbriani M. 1993. Urinary excretion of unmetabolized benzene as an indicator of benzene exposure. J Toxicol Environ Health. 38(3):233–243.
  • Ghittori S, Maestri L, Fiorentino ML, Imbriani M. 1995. Evaluation of occupational exposure to benzene by urinalysis. Int Arch Occup Environ Health. 67(3):195–200.
  • Hamilton A. 1922. The growing menace of benzene (benzol) poisoning in American industry. J Am Med Assoc. 78(9):627–630.
  • Hanke J, Dutkiewicz T, Piotrowski J. 2000. The absorption of benzene through human skin. Int J Occup Environ Health. 6(2):104–111.
  • Hanway R, Cavicchioli A, Kaur B, Parsons J, Lamb JH, Buckberry LD, Farmer PB. 2000. Analysis of S-phenyl-L-cysteine in globin as a marker of benzene exposure. Biomarkers. 5(4):252–262.
  • Hays SM, Aylward LL, LaKind JS, Bartels MJ, Barton HA, Boogaard PJ, Brunk C, DiZio S, Dourson M, Goldstein DA, Biomonitoring Equivalents Expert Workshop, et al. 2008. Guidelines for the derivation of biomonitoring equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol. 51(3 Suppl):S4–S15.
  • Hays SM, Pyatt DW, Kirman CR, Aylward LL. 2012. Biomonitoring equivalents for benzene. Regul Toxicol Pharmacol. 62(1):62–73.
  • Hotz P, Carbonnelle P, Haufroid V, Tschopp A, Buchet JP, Lauwerys R. 1997. Biological monitoring of vehicle mechanics and other workers exposed to low concentrations of benzene. Int Arch Occup Environ Health. 70(1):29–40.
  • IARC. 1982. Some industrial chemicals and dyestuffs. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, 29. Geneva (Switzerland): WHO Press.
  • IARC. 2018. Benzene. IARC monographs on the evaluation of the carcinogenic risks to humans, 120. Geneva (Switzerland): WHO Press.
  • IARC. 1974. Sorne anti-thyroid and related substances, nitrofurans and Indus trial chemicals. IARC Monogr Eval Carcinogenic Risk Chem Humans. 7:203–221.
  • IARC. 1987. Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1–42. IARC Monogr Suppl. 7:120–122.
  • IARC. 2012. Chemical agents and related occupations – a review of human carcinogens: benzene. IARC Monogr Eval Carcin Risks Human. 100F:248–294.
  • Inoue O, Kanno E, Yusa T, Kakizaki M, Ukai H, Okamoto S, Higashikawa K, Ikeda M. 2002. Urinary benzylmercapturic acid as a marker of occupational exposure to toluene. Int Arch Occup Environ Health. 75(5):341–347.
  • Inoue O, Seiji K, Kasahara M, Nakatsuka H, Watanabe T, Yin SG, Li GL, Jin C, Cai SX, Wang XZ. 1986. Quantitative relation of urinary phenol levels to breathzone benzene concentrations: a factory survey. Br J Ind Med. 43(10):692–697.
  • Jakasa I, Kezic S, Boogaard PJ. 2015. Dermal uptake of petroleum substances. Toxicol Lett. 235(2):123–139.
  • Johnson ES, Langard S, Lin YS. 2007. A critique of benzene exposure in the general population. Sci Total Environ. 374(2-3):183–198.
  • Kawai T, Ukai H, Inoue O, Maejima Y, Fukui Y, Ohashi F, Okamoto S, Takada S, Sakurai H, Ikeda M. 2008. Evaluation of biomarkers of occupational exposure to toluene at low levels. Int Arch Occup Environ Health. 81(3):253–262.
  • Kim S, Vermeulen R, Waidyanatha S, Johnson BA, Lan Q, Smith MT, Zhang L, Li G, Shen M, Yin S, et al. 2006. Modeling human metabolism of benzene following occupational and environmental exposures. Cancer Epidemiol Biomarkers Prev. 15(11):2246–2252.
  • Knudsen LE, Tolonen H, Scheepers PTJ, Loots I, Vorkamp K, Hajeb P, Sepai O, Gilles L, Splanemann P, Weise P, et al. 2022. Implementation and coordination of an ethics framework in HBM4EU – experiences and reflections. Int J Hyg Environ Health. 248:114098.
  • Knutsen JS, Kerger BD, Finley B, Paustenbach DJ. 2013. A calibrated human PBPK model for benzene inhalation with urinary bladder and bone marrow compartments. Risk Anal. 33(7):1237–1251.
  • Kok PW, Ong CN. 1994. Blood and urinary benzene determined by headspace gas chromatography with photoionization detection: application in biological monitoring of low-level nonoccupational exposure. Int Arch Occup Environ Health. 66(3):195–201.
  • Kraus T, Bader M, Klotz K, Weistenhöfer W, Drexler H, Hartwig A, MAK Commission. 2018. Addendum zu Benzol - BAT Value Documentation in German language. The MAK Collect Occup Health Safe. 3(1):262–294.
  • LaKind JS, Aylward LL, Brunk C, DiZio S, Dourson M, Goldstein DA, Kilpatrick ME, Krewski D, Bartels MJ, Barton HA, Biomonitoring Equivalents Expert Workshop, et al. 2008. Guidelines for the communication of biomonitoring equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol. 51(3 Suppl):S16–S26.
  • Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, et al. 2004. Hematotoxicity in workers exposed to low levels of benzene. Science. 306(5702):1774–1776.
  • Le Noir, MM, Claude H. 1897. Sur un cas de purpura attribué à l’intoxication par le benzène. Bull Mém Soc Hop Paris. 14:1251–1260.
  • Lin YS, McKelvey W, Waidyanatha S, Rappaport SM. 2006. Variability of albumin adducts of 1,4-benzoquinone, a toxic metabolite of benzene, in human volunteers. Biomarkers. 11(1):14–27.
  • Lin YS, Vermeulen R, Tsai CH, Waidyanatha S, Lan Q, Rothman N, Smith MT, Zhang L, Shen M, Li G, et al. 2007. Albumin adducts of electrophilic benzene metabolites in benzene-exposed and control workers. Environ Health Perspect. 115(1):28–34.
  • Maestri L, Negri S, Ferrari M, Ghittori S, Imbriani M. 2005. Determination of urinary S-phenylmercapturic acid, a specific metabolite of benzene, by liquid chromatography/single quadrupole mass spectrometry. Rapid Commun Mass Spectrom. 19(9):1139–1144.
  • Manini P, De Palma G, Andreoli R, Poli D, Mozzoni P, Folesani G, Mutti A, Apostoli P. 2006. Environmental and biological monitoring of benzene exposure in a cohort of Italian taxi drivers. Toxicol Lett. 167(2):142–151.
  • Manini P, De Palma G, Andreoli R, Poli D, Petyx M, Corradi M, Mutti A, Apostoli P. 2008. Biological monitoring of low benzene exposure in Italian traffic policemen. Toxicol Lett. 181(1):25–30.
  • Mansfield CB. 1849. Untersuchung des Steinkohlentheers. Justus Liebigs Annalen der Chemie. 69(2):162–180.
  • Mansi A, Bruni R, Capone P, Paci E, Pigini D, Simeoni C, Gnerre R, Papacchini M, Tranfo G. 2012. Low occupational exposure to benzene in a petrochemical plant: modulating effect of genetic polymorphisms and smoking habit on the urinary t,t-MA/SPMA ratio. Toxicol Lett. 213(1):57–62.
  • McDonald TA, Holland NT, Skibola C, Duramad P, Smith MT. 2001. Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia. Leukemia. 15(1):10–20.
  • McHale CM, Zhang L, Lan Q, Vermeulen R, Li G, Hubbard AE, Porter KE, Thomas R, Portier CJ, Shen M, et al. 2011. Global gene expression profiling of a population exposed to a range of benzene levels. Environ Health Perspect. 119(5):628–634.
  • McNally K, Sams C, Loizou GD, Jones K. 2017. Evidence for non-linear metabolism at low benzene exposures? A reanalysis of data. Chem Biol Interact. 278:256–268.
  • Ong CN, Kok PW, Ong HY, Shi CY, Lee BL, Phoon WH, Tan KT. 1996. Biomarkers of exposure to low concentrations of benzene: a field assessment. Occup Environ Med. 53(5):328–333.
  • Ong CN, Lee BL. 1994. Determination of benzene and its metabolites: application in biological monitoring of environmental and occupational exposure to benzene. J Chromatogr B Biomed Appl. 660(1):1–22.
  • Paustenbach DJ, PS, Price W, Ollison C, Blank JD, Jernigan RD, Bass, HD, Peterson. 1992. Reevaluation of benzene exposure for the Pliofilm (rubberworker) cohort (1936–1976). J Toxicol Environ Health. 36(3):177–231.
  • Perbellini L, Faccini GB, Pasini F, Cazzoli F, Pistoia S, Rosellini R, Valsecchi M, Brugnone F. 1988. Environmental and occupational exposure to benzene by analysis of breath and blood. Br J Ind Med. 45(5):345–352.
  • Perbellini L, Pasini F, Romani S, Princivalle A, Brugnone F. 2002. Analysis of benzene, toluene, ethylbenzene and m-xylene in biological samples from the general population. J Chromatogr B Analyt Technol Biomed Life Sci. 778(1-2):199–210.
  • Perbellini L, Princivalle A, Cerpelloni M, Pasini F, Brugnone F. 2003. Comparison of breath, blood and urine concentrations in the biomonitoring of environmental exposure to 1,3-butadiene, 2,5-dimethylfuran, and benzene. Int Arch Occup Environ Health. 76(6):461–466.
  • Plebani C, Tranfo G, Salerno A, Panebianco A, Marcelloni AM. 1999. An optimized sampling and GC-MS analysis method for benzene in exhaled breath, as a biomarker for occupational exposure. Talanta. 50(2):409–412.
  • RAC. 2018. Opinion of the Committee for Risk Assessment on the evaluation of the occupational exposure limits (OELs) for benzene (adopted 9 March 2018). Helsinki, Finland: E. C. Agency.
  • Rappaport SM, Waidyanatha S, Qu Q, Shore R, Jin X, Cohen B, Chen LC, Melikian AA, Li G, Yin S, et al. 2002. Albumin adducts of benzene oxide and 1,4-benzoquinone as measures of human benzene metabolism. Cancer Res. 62(5):1330–1337.
  • Rappaport SM, Waidyanatha S, Yeowell-O'Connell K, Rothman N, Smith MT, Zhang L, Qu Q, Shore R, Li G, Yin S. 2005. Protein adducts as biomarkers of human benzene metabolism. Chem Biol Interact. 153–154:103–109.
  • Rolleston HD, Boyd EJ. 1914. Lymphocytic leukaemia under treatment by benzol. Proc R Soc Med 7(Sect Study Dis Child):71–73.
  • Ross JN. 1914. Benzol in the treatment of lymphatic leukaemia. Proc R Soc Med 7(Sect Study Dis Child):129–132.
  • Santesson CG. 1897. Ueber chronische Vergiftungen mit Steinkohlentheerbenzin; vier Totesfälle. Nach klinischen und pathologisch-anatomischen Beobachtungen mehrerer Collegen und mit beleuchtenden Thierexperimenten. Archiv für Hygiene. 31:336–376.
  • Scherer G, Renner T, Meger M. 1998. Analysis and evaluation of trans, trans-muconic acid as a biomarker for benzene exposure. J Chromatogr B Biomed Sci Appl. 717(1–2):179–199.
  • Schnatter AR, Rooseboom M, Kocabas NA, North CM, Dalzell A, Twisk J, Faulhammer F, Rushton E, Boogaard PJ, Ostapenkaite V, et al. 2020. Derivation of an occupational exposure limit for benzene using epidemiological study quality assessment tools. Toxicol Lett. 334:117–144.
  • Selling L. 1910. A preliminary report of some cases of purpura haemorrhagica due to benzol poisoning. Bull Johns Hopkins Hosp. 21:33–36.
  • Selling L. 1916. Benzol as leucotoxin. Studies on the degeneration and regeneration of the blood and haematopoietic system. John Hopkins Hosp Rep. 17:83–148.
  • Sinclair GC, Gray CN, Sherwood RJ. 1999. Structure and validation of a pharmacokinetic model for benzene. Am Ind Hyg Assoc J. 60(2):249–258.
  • Stolkind E. 1931. Polycythaemia vera (Vaquez’ disease) treated by benzol, Roentgen therapy and phenylhydrazine. Complications. Proc Royal Soc Med. 24:925–928.
  • Teisinger J, Fiserova-Bergerova , Mensikova J. 1955. Valeur comparée de la détermination des sulfates et du phénol contenus dans l‘urine pour l‘évaluation de la concentration du benzène dans l‘air. Archives des maladies professionnelles de médicine du travail et de securité sociale 16(1):221–232.
  • Thomas R, Hubbard AE, McHale CM, Zhang L, Rappaport SM, Lan Q, Rothman N, Vermeulen R, Guyton KZ, Jinot J, et al. 2014. Characterization of changes in gene expression and biochemical pathways at low levels of benzene exposure. PLOS One. 9(5):e91828.
  • Tolentino D, Zenari E, Dall’Olio M, Ruani G, Gelormini A, Mirone G. 2003. Application of statistical models to estimate the correlation between urinary benzene as biological indicator of exposure and air concentrations determined by personal monitoring. AIHA J. 64(5):625–629.
  • Travis CC, Quillen JL, Arms AD. 1990. Pharmacokinetics of benzene. Toxicol Appl Pharmacol. 102(3):400–420.
  • Ukai H, Kawai T, Inoue O, Maejima Y, Fukui Y, Ohashi F, Okamoto S, Takada S, Sakurai H, Ikeda M. 2007. Comparative evaluation of biomarkers of occupational exposure to toluene. Int Arch Occup Environ Health. 81(1):81–93.
  • Valcke M, Haddad S. 2015. Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene. J Toxicol Environ Health A. 78(7):409–431.
  • van Haaften A, Sie ST. 1965. The measurement of phenol in urine by gas chromatography as a check on benzene exposure. Am Ind Hyg Assoc J. 26:52–58.
  • van Sittert NJ, Boogaard PJ, Beulink GD. 1993. Application of the urinary S-phenylmercapturic acid test as a biomarker for low levels of exposure to benzene in industry. Br J Ind Med. 50(5):460–469.
  • Vermeulen R, Li G, Lan Q, Dosemeci M, Rappaport SM, Bohong X, Smith MT, Zhang L, Hayes RB, Linet M, et al. 2004. Detailed exposure assessment for a molecular epidemiology study of benzene in two shoe factories in China. Ann Occup Hyg. 48(2):105–116.
  • Vigliani EC, Saita G. 1948. Alcune considerazioni sulle leucemie da benzolo. Med Lav. 39(2):41–44.
  • Vigliani EC, Saita G. 1964. Benzene and leukemia. N Engl J Med. 271:872–876.
  • Waidyanatha S, Rothman N, Fustinoni S, Smith MT, Hayes RB, Bechtold W, Dosemeci M, Guilan L, Yin S, Rappaport SM. 2001. Urinary benzene as a biomarker of exposure among occupationally exposed and unexposed subjects. Carcinogenesis. 22(2):279–286.
  • Weaver VM, Buckley T, Groopman JD. 2000. Lack of specificity of trans,trans-muconic acid as a benzene biomarker after ingestion of sorbic acid-preserved foods. Cancer Epidemiol Biomarkers Prev. 9(7):749–755.
  • Weber FP. 1914. Chronic myelocytic leukaemia treated by benzol, &c. Proc R Soc Med. 7(Clin Sect):39–41.
  • Weiskotten HG, Gibbs CB, Boggs EO, Templeton ER. 1920. The action of benzol: VI. benzol. J Med Res. 41(4):425–438.
  • Williams PR, Paustenbach DJ. 2003. Reconstruction of benzene exposure for the Pliofilm cohort (1936–1976) using Monte Carlo techniques. J Toxicol Environ Health A. 66(8):677–781.
  • Yeowell-O'Connell K, McDonald TA, Rappaport SM. 1996. Analysis of hemoglobin adducts of benzene oxide by gas chromatography-mass spectrometry. Anal Biochem. 237(1):49–55.
  • Yeowell-O'Connell K, Rothman N, Smith MT, Hayes RB, Li G, Waidyanatha S, Dosemeci M, Zhang L, Yin S, Titenko-Holland N, et al. 1998. Hemoglobin and albumin adducts of benzene oxide among workers exposed to high levels of benzene. Carcinogenesis. 19(9):1565–1571.
  • Yeowell-O'Connell K, Rothman N, Waidyanatha S, Smith MT, Hayes RB, Li G, Bechtold WE, Dosemeci M, Zhang L, Yin S, et al. 2001. Protein adducts of 1,4-benzoquinone and benzene oxide among smokers and nonsmokers exposed to benzene in China. Cancer Epidemiol Biomarkers Prev. 10(8):831–838.
  • Yokley K, Tran HT, Pekari K, Rappaport S, Riihimaki V, Rothman N, Waidyanatha S, Schlosser PM. 2006. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach. Risk Anal. 26(4):925–943.